Merck & Company (MRK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MRK | NVS | NVO | ||
| Company | Merck & Company | Novartis Ag ADR | Novo Nordisk A/S ADR | ||
| Price Information | |||||
| Exchange | NYSE | NYSE | NYSE | ||
| Open | 121.40 | 163.87 | 48.72 | ||
| High | 122.60 | 164.02 | 48.77 | ||
| Low | 120.50 | 162.53 | 48.18 | ||
| Latest | 121.86 | 163.92 | 48.45 | ||
| Change | +0.20 | -1.46 | -0.78 | ||
| % Change | +0.16% | -0.88% | -1.58% | ||
| Volume | 8,933,300 | 1,836,300 | 8,289,400 | ||
| 20-Day Average Volume | 13,485,715 | 2,492,090 | 23,014,449 | ||
| Previous Close | 121.66 | 165.38 | 49.23 | ||
| Industry | Large Cap Pharma | Large Cap Pharma | Large Cap Pharma | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 115.36 | 154.91 | 53.53 | ||
| 20-Day Raw Stochastic | 91.50% | 83.17% | 24.90% | ||
| 20-Day Relative Strength | 68.80 | 73.98 | 42.02 | ||
| Weighted Alpha | +51.62 | +58.49 | -32.46 | ||
| Today's Opinion | 100% Buy | 100% Buy | 56% Sell | ||
| Previous Opinion | 100% Buy | 100% Buy | 56% Sell | ||
| Last Month's Opinion | 100% Buy | 100% Buy | 24% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.14% since 02/11/26 | +2.41% since 02/11/26 | -0.59% since 02/11/26 | ||
| Low | 118.12 on 02/12/26 | 159.47 on 02/12/26 | 48.12 on 02/12/26 | ||
| High | 123.33 on 02/13/26 | 167.86 on 02/18/26 | 50.07 on 02/12/26 | ||
| 1-Month | |||||
| %Chg | +11.97% since 01/16/26 | +13.57% since 01/16/26 | -22.27% since 01/16/26 | ||
| Low | 106.03 on 01/28/26 | 142.82 on 01/20/26 | 43.24 on 02/05/26 | ||
| High | 123.33 on 02/13/26 | 167.86 on 02/18/26 | 64.16 on 01/23/26 | ||
| 3-Month | |||||
| %Chg | +28.21% since 11/19/25 | +28.76% since 11/19/25 | -1.12% since 11/19/25 | ||
| Low | 93.90 on 11/20/25 | 123.24 on 11/20/25 | 43.08 on 11/24/25 | ||
| High | 123.33 on 02/13/26 | 167.86 on 02/18/26 | 64.16 on 01/23/26 | ||
| 6-Month | |||||
| %Chg | +43.48% since 08/19/25 | +31.19% since 08/19/25 | -11.56% since 08/19/25 | ||
| Low | 77.58 on 09/25/25 | 121.57 on 10/29/25 | 43.08 on 11/24/25 | ||
| High | 123.33 on 02/13/26 | 167.86 on 02/18/26 | 64.16 on 01/23/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 301,962,912 | 349,352,384 | 219,811,936 | ||
| Shares Outstanding, K | 2,482,023 | 2,112,422 | 4,465,000 | ||
| Annual Sales | 65,011,000,000 | 56,674,000,000 | 46,792,290,000 | ||
| Annual Net Income | 18,254,000,000 | 13,984,000,000 | 15,508,510,000 | ||
| Last Quarter Sales | 16,400,000,000 | 13,860,000,000 | 12,343,020,000 | ||
| Last Quarter Net Income | 2,963,000,000 | 2,409,000,000 | 4,247,770,000 | ||
| 60-Month Beta | 0.28 | 0.50 | 0.67 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 2.04 on 02/03/26 | 2.03 on 02/04/26 | 1.02 on 11/05/25 | ||
| Latest Earnings Date | 04/23/26 | 05/05/26 | 05/06/26 | ||
| Most Recent Dividend | 0.850 on 12/15/25 | 2.596 on 03/12/25 | 0.412 on 08/18/25 | ||
| Next Ex-Dividends Date | 03/16/26 | 03/11/26 | 03/30/26 | ||
| Ratios | |||||
| Price/Earnings ttm | 13.55 | 18.50 | 12.63 | ||